FDA Warning Letter — Germaphobix

Case 720555 — FEI 3036047763

The FDA took a Warning Letter action against Germaphobix on Jan 9, 2026 (Tampa, FL). The action was issued by CBER and concerns biologics products.

Action Details

Facility
Germaphobix
Date
Jan 9, 2026
Fiscal Year
2026
Product Type
Biologics
Center
CBER
Location
Tampa, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.